Skip to main content

Continuity of Pharmacotherapy for Opioid Use Disorder

CBE ID
3175
Endorsement Status
Endorsed
1.0 New or Maintenance
Maintenance
1.1 Measure Structure
Single Measure
Previous Endorsement Cycle
Spring 2021
Is Under Review
No
Next Maintenance Cycle
Spring 2026
1.6 Measure Description

Percentage of adults of at least 18 years of age with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment

Measure Specs
General Information
1.7 Measure Type
Process
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
Clinician: Group/Practice
Clinician: Individual
Health Plan
1.20 Types of Data Sources
Claims Data